NFKB1 and neoplasm: Functional evidence and signaling pathway studies indicate that MCC acts as a tumor suppressor gene by inhibiting the oncogenic NF-κB and β-catenin pathways in CRCs and hepatocellular carcinoma [20,27,31–36].